These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6192001)

  • 1. Nomifensine antagonizes the ouabain-induced increase in dopamine metabolites in cerebrospinal fluid of the rat.
    Elghozi JL; Le Quan-Bui KH; Devynck MA; Meyer P
    Eur J Pharmacol; 1983 Jun; 90(2-3):279-82. PubMed ID: 6192001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of drug-induced changes in dopamine and serotonin metabolite concentrations in the CSF of the rat.
    Mignot E; Laude D; Elghozi JL
    J Neurochem; 1984 Mar; 42(3):819-25. PubMed ID: 6198472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of dopamine turnover by monitoring the decline of dopamine metabolites in rat CSF after alpha-methyl-p-tyrosine.
    Mignot E; Laude D
    J Neurochem; 1985 Nov; 45(5):1527-33. PubMed ID: 2864397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probenecid sensitive pathway of elimination of dopamine and serotonin metabolites in CSF of the rat.
    Elghozi JL; Mignot E; Le Quan-Bui KH
    J Neural Transm; 1983; 57(1-2):85-94. PubMed ID: 6194256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subchronic methamphetamine treatment enhances ouabain-induced striatal dopamine efflux in vivo.
    Kanzaki A; Akiyama K; Otsuki S
    Brain Res; 1992 Jan; 569(2):181-8. PubMed ID: 1371707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
    Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
    Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
    Barkai AI; Kowalik S; Reches A
    Psychopharmacology (Berl); 1984; 84(3):352-5. PubMed ID: 6083575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Kaakkola S; Wurtman RJ
    Brain Res; 1992 Aug; 587(2):241-9. PubMed ID: 1381981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central administration of yohimbine increases free 3-methoxy-4-hydroxyphenylglycol in the cerebrospinal fluid of the rat.
    Mignot E; Laude D; Elghozi JL; Le Quan-Bui KH; Meyer P
    Eur J Pharmacol; 1982 Sep; 83(1-2):135-8. PubMed ID: 6182009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of brain dopamine metabolism by tyrosine during immobilisation: an in vivo study using repeated cerebrospinal fluid sampling in conscious rats.
    Marcou M; Kennett GA; Curzon G
    J Neurochem; 1987 Apr; 48(4):1245-51. PubMed ID: 2434619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo.
    Santiago M; Machado A; Cano J
    Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular microdialysis: a new method for determining monoamine metabolite concentrations in the cerebrospinal fluid of freely moving rats.
    Becker JB; Adams F; Robinson TE
    J Neurosci Methods; 1988 Jul; 24(3):259-69. PubMed ID: 2458511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between high-performance liquid chromatography and automated fluorimetric methods for the determination of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid and 5-hydroxyindoleacetic acid in nervous tissue and cerebrospinal fluid.
    Westerink BH
    J Chromatogr; 1982 Dec; 233():69-77. PubMed ID: 6186680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
    Bagdy G; Perényi A; Frecska E; Révai K; Papp Z; Fekete MI; Arató M
    Psychopharmacology (Berl); 1985; 85(1):62-4. PubMed ID: 2580329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemiballismus: changes in cerebrospinal fluid.
    Kostic V; Djuricic B; Paschen W
    Acta Neurol Scand; 1988 Aug; 78(2):115-7. PubMed ID: 2459894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain.
    Broch OJ
    Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent determination of brain dopamine and 5-hydroxytryptamine turnovers in individual freely moving rats using repeated sampling of cerebrospinal fluid.
    Hutson PH; Sarna GS; Kantamaneni BD; Curzon G
    J Neurochem; 1984 Jul; 43(1):151-9. PubMed ID: 6202842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 2,4-dichlorophenoxyacetic acid (2,4-D) on biogenic amines and their acidic metabolites in brain and cerebrospinal fluid of rats.
    Elo HA; MacDonald E
    Arch Toxicol; 1989; 63(2):127-30. PubMed ID: 2471493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.